UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IS LOCAL A MATTER OF FOOD MILES OR FOOD TRADITIONS?

Italian journal of food science, 2017-07, Vol.29 (3), p.505

2017

Volltextzugriff (PDF)

Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA

Clinical rheumatology, 2018-02, Vol.37 (2), p.315-321

2018

Volltextzugriff (PDF)

POS0593 THE REDUCTION OF RETINAL MICROVASCULAR ALTERATIONS AND THE DECREASE OF A POTENTIALLY RELATED T-CELL SUBSET IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.530-530

2021

Volltextzugriff (PDF)

Evaluating USA’s New Nutrition and Supplement Facts Label: Evidence from a Non-hypothetical Choice Experiment

Journal of consumer policy, 2019-12, Vol.42 (4), p.545-562

2019

Volltextzugriff (PDF)

S04.1 Disease activity and clinical remission in systemic lupus erythematosus: comparison between patient and physician perspectives by means of patient reported outcomes (PROS)

Lupus science & medicine, 2022-10, Vol.9 (Suppl 2), p.A5-A6

2022

Volltextzugriff (PDF)

FRI0114 Efficacy and retention rate of certolizumab pegol in rheumatoid arthritis: data from a large real-life multicentre retrospective cohort

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.601

2018

Volltextzugriff (PDF)

FRI0214 Six-Year Retention Rate of Abatacept in Rheumatoid Arthritis: A Multicentric Retrospective Analysis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.509-509

2016

Volltextzugriff (PDF)

SAT0159 Long-Term Follow-Up of Children Born to Mothers with Chronic Arthritides and Exposed in Utero to Anti-TNF-Alpha Agents: A Case-Control Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.709-710

2015

Volltextzugriff (PDF)

THU0264 Efficacy and Safety of Cyclosporine-A During Pregnancy in Autoimmune Diseases

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A254-A255

2013

Volltextzugriff (PDF)

FRI0176 Safety of anti-TNF Alfa Agents during Pregancy and Breastfeeding: Longterm Follow up of Exposed Children in A Case-Series of Mothers with Chronic Arthritides

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.493-493

2016

Volltextzugriff (PDF)

Inflammatory molecules: A target for treatment of systemic autoimmune diseases

Autoimmunity reviews, 2007-11, Vol.7 (1), p.1-7

2007

Volltextzugriff (PDF)

Selective melanocortin MC 4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage

British journal of pharmacology, 2009-01, Vol.150 (5), p.595-603

2009

Volltextzugriff (PDF)

AB0430 MEDICATION ADHERENCE IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS TREATED WITH BIOLOGIC OR TARGET SYNTETIC -DMARDS: EVALUATION OF PREDICTIVE FACTORS IN AN ITALIAN MONOCENTRIC COHORT

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1404-1404

2023

Volltextzugriff (PDF)

AB0313 Factors predicting disability in patients affected by long-standing rheumatoid arthritis treated with anti-TNF drugs: An observational study

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.655-655

2013

Volltextzugriff (PDF)

AB0712 CLINICAL FEATURES OF RHEUMATOID ARTHRITIS PATIENTS ELIGIBLE FOR JAK-INHIBITOR THERAPY: AN ASSESSMENT BEFORE VERSUS AFTER EMA RECOMMENDATIONS TO MINIMIZE CARDIOVASCULAR, THROMBOEMBOLIC, AND NEOPLASTIC RISKS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1645-1646

2024

Volltextzugriff (PDF)

Treatment of lupus skin involvement with quinacrine and hydroxychloroquine

Lupus, 2009-07, Vol.18 (8), p.735-739

2009

Volltextzugriff (PDF)

POS0545 DISCORDANCE BETWEEN PATIENT’S AND PHYSICIAN’S DISEASE ACTIVITY ASSESSMENT IN RHEUMATOID ARTHRITIS: WHICH DOMAINS CAN INFLUENCE THIS DISCREPANCY WHEN REMISSION IS ACHIEVED?

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.507-507

2021

Volltextzugriff (PDF)

Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage

British journal of pharmacology, 2007-03, Vol.150 (5), p.595-603

2007

Volltextzugriff (PDF)

POS0117 DISEASE ACTIVITY AND CLINICAL REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS: COMPARISON BETWEEN PATIENT AND PHYSICIAN PERSPECTIVES BY MEANS OF PATIENT REPORTED OUTCOMES (PROs)

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.283-284

2022

Volltextzugriff (PDF)

POS0992-HPR THE EFFECT OF CENTRAL SENSITIZATION ON DISEASE SEVERITY LEVELS AND PRESENTEEISM-RELATED PRODUCTIVITY LOSS IN FEMALE WORKERS WITH RA

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.812-813

2023

Volltextzugriff (PDF)

OP0012-HPR CENTRAL SENSITIZATION HAS MAJOR IMPACT ON DISEASE ACTIVITY, FUNCTIONAL DISABILITY AND FRAILTY IN PATIENTS WITH RA

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.8-9

2023

Volltextzugriff (PDF)

POS1388-HPR RELATIONSHIP BETWEEN CENTRAL SENSITIZATION AND PSYCHOLOGICAL FACTORS IN RHEUMATOID ARTHRITIS: A CROSS-SECTIONAL, MULTICENTER STUDY

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1047-1048

2023

Volltextzugriff (PDF)

CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept

Clinical and experimental rheumatology, 2022-11

2022

Volltextzugriff (PDF)

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

Reumatismo, 2008-01, Vol.60 (1), p.22-27

2008

Volltextzugriff (PDF)

AB0224 JAK-INHIBITORS ATTAIN A RAPID AND PERSISTENT EFFECTIVENESS ON SEVERAL PATIENT-REPORTED OUTCOMES IN LONG-STANDING RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1239-1240

2022

Volltextzugriff (PDF)

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

IS LOCAL A MATTER OF FOOD MILES OR FOOD TRADITIONS?

Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA

POS0593 THE REDUCTION OF RETINAL MICROVASCULAR ALTERATIONS AND THE DECREASE OF A POTENTIALLY RELATED T-CELL SUBSET IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT

Evaluating USA’s New Nutrition and Supplement Facts Label: Evidence from a Non-hypothetical Choice Experiment

S04.1 Disease activity and clinical remission in systemic lupus erythematosus: comparison between patient and physician perspectives by means of patient reported outcomes (PROS)

FRI0114 Efficacy and retention rate of certolizumab pegol in rheumatoid arthritis: data from a large real-life multicentre retrospective cohort

FRI0214 Six-Year Retention Rate of Abatacept in Rheumatoid Arthritis: A Multicentric Retrospective Analysis

SAT0159 Long-Term Follow-Up of Children Born to Mothers with Chronic Arthritides and Exposed in Utero to Anti-TNF-Alpha Agents: A Case-Control Study

THU0264 Efficacy and Safety of Cyclosporine-A During Pregnancy in Autoimmune Diseases

FRI0176 Safety of anti-TNF Alfa Agents during Pregancy and Breastfeeding: Longterm Follow up of Exposed Children in A Case-Series of Mothers with Chronic Arthritides

Inflammatory molecules: A target for treatment of systemic autoimmune diseases

Selective melanocortin MC 4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage

AB0430 MEDICATION ADHERENCE IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS TREATED WITH BIOLOGIC OR TARGET SYNTETIC -DMARDS: EVALUATION OF PREDICTIVE FACTORS IN AN ITALIAN MONOCENTRIC COHORT

AB0313 Factors predicting disability in patients affected by long-standing rheumatoid arthritis treated with anti-TNF drugs: An observational study

AB0712 CLINICAL FEATURES OF RHEUMATOID ARTHRITIS PATIENTS ELIGIBLE FOR JAK-INHIBITOR THERAPY: AN ASSESSMENT BEFORE VERSUS AFTER EMA RECOMMENDATIONS TO MINIMIZE CARDIOVASCULAR, THROMBOEMBOLIC, AND NEOPLASTIC RISKS

Treatment of lupus skin involvement with quinacrine and hydroxychloroquine

POS0545 DISCORDANCE BETWEEN PATIENT’S AND PHYSICIAN’S DISEASE ACTIVITY ASSESSMENT IN RHEUMATOID ARTHRITIS: WHICH DOMAINS CAN INFLUENCE THIS DISCREPANCY WHEN REMISSION IS ACHIEVED?

Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage

POS0117 DISEASE ACTIVITY AND CLINICAL REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS: COMPARISON BETWEEN PATIENT AND PHYSICIAN PERSPECTIVES BY MEANS OF PATIENT REPORTED OUTCOMES (PROs)

POS0992-HPR THE EFFECT OF CENTRAL SENSITIZATION ON DISEASE SEVERITY LEVELS AND PRESENTEEISM-RELATED PRODUCTIVITY LOSS IN FEMALE WORKERS WITH RA

OP0012-HPR CENTRAL SENSITIZATION HAS MAJOR IMPACT ON DISEASE ACTIVITY, FUNCTIONAL DISABILITY AND FRAILTY IN PATIENTS WITH RA

POS1388-HPR RELATIONSHIP BETWEEN CENTRAL SENSITIZATION AND PSYCHOLOGICAL FACTORS IN RHEUMATOID ARTHRITIS: A CROSS-SECTIONAL, MULTICENTER STUDY

CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

AB0224 JAK-INHIBITORS ATTAIN A RAPID AND PERSISTENT EFFECTIVENESS ON SEVERAL PATIENT-REPORTED OUTCOMES IN LONG-STANDING RHEUMATOID ARTHRITIS

Suchergebnisse filtern